Total Funding
3
23
Total FundingGrant raised
Growth Score 3 in past quarter
-1 pts
Heat Score 23 in past quarter
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
526431
TheraJect, Inc. is a preclinical stage biopharmaceutical company
- Sung-Yun Kwon: CEO & Founder
About the Company
TheraJect, Inc. is a preclinical stage biopharmaceutical
company committed to the drug delivery including vaccines
via a novel, needle-free transdermal technology.
TheraJect is focused on enhancing the efficacy of existing
vaccines, enabling new vaccines and expanding the global
vaccine market.
